AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Empagliflozin 10mg
3 registrations across 3 African markets— 3 active
Markets with Empagliflozin 10mg
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| EMGLY 10 TABLETS (Each film coated tablet contains Empagliflozin 10mg) | 🇬🇭Ghana | — | active | Jul 2031 |
| EMPAPRIDE 10 Film-coated Tablets | 🇿🇲Zambia | MICRO LABS LTD | active | Jun 2031 |
| Empator 10mg Tablet Tablet | 🇰🇪Kenya | MARTIN DOW LIMITED | active | Mar 2028 |
Empagliflozin 10mg in Africa — Regulatory Overview
Empagliflozin 10mg is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 3 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.